[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fi2tuH6-0zuIsQVQvakeG3S8me8Ow3Fb1JgzTZTlbrgg":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":69,"rows":76},"Jagiellonian University",[4],155,false,31,6,77675,11,123,[14,17,20,22,24,27,29,31],{"name":15,"count":16},"Gastric Cancer",5,{"name":18,"count":19},"Endometriosis",4,{"name":21,"count":19},"Rectal Cancer",{"name":23,"count":19},"Infertility Unexplained",{"name":25,"count":26},"Hypertension",3,{"name":28,"count":26},"Infertility, Female",{"name":30,"count":26},"Pain, Postoperative",{"name":32,"count":26},"Reproductive Age",[34,39,44,49,54,59,64],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT05279651","Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)","2025-04-30","Ivabradine",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT04597294","Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence","2026-01","FLOT + HIPEC + Surgery",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT05272371","Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive Disease","2026-09-30","Chemoimmunotherapy",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT06793527","Comparison of the Efficacy of Celiac Plexus Blockade, ESP and Lidocaine Infusion Under OFA","2026-12-31","Celiac Plexus Block",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT06885268","Noradrenaline Versus Standard Blood Pressure Management for Perioperative Hypotension in Non-cardiac Surgery","2027-06-30","noradrenaline infusion for management blood pressure",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT07378189","Opioid-free Anesthesia as an Alternative to General Anesthesia in Patients Undergoing Laparoscopic Peripheral Pancreatic Resection","2027-12-31","Balanced anesthesia with opioids",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT06249802","Beta-blockade in Unruptured Intracranial Aneurysm","2029-01-01","Nebivolol",[70,71,72,73,74,75],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[77,102,127,145,167,185,209,230,251,275,293,311,352,382,400,425,443,461,492,510,528,546,576,594,612,630,648,677,695,721,739,764,802,829,847,872,890,914,941,968,986,1013,1036,1062,1080,1106,1134,1152,1177,1195,1222,1240,1265],{"intervention":68,"totalTrials":78,"cells":79},1,{"EARLY_PHASE1":80,"PHASE1":83,"PHASE2":85,"PHASE3":87,"PHASE4":89,"NA":100},{"trials":81,"activeCount":82},[],0,{"trials":84,"activeCount":82},[],{"trials":86,"activeCount":82},[],{"trials":88,"activeCount":82},[],{"trials":90,"activeCount":78,"soonestReadout":67},[91],{"nctId":65,"briefTitle":66,"status":92,"phases":93,"primaryCompletion":67,"completion":94,"start":95,"enrollment":96,"conditions":97,"interventions":99},"NOT_YET_RECRUITING",[74],"2030-01-01","2025-01-01",100,[98],"Intracranial Aneurysm",[68],{"trials":101,"activeCount":82},[],{"intervention":58,"totalTrials":78,"cells":103},{"EARLY_PHASE1":104,"PHASE1":106,"PHASE2":108,"PHASE3":110,"PHASE4":123,"NA":125},{"trials":105,"activeCount":82},[],{"trials":107,"activeCount":82},[],{"trials":109,"activeCount":82},[],{"trials":111,"activeCount":78,"soonestReadout":57},[112],{"nctId":55,"briefTitle":56,"status":113,"phases":114,"primaryCompletion":57,"completion":57,"start":115,"enrollment":116,"conditions":117,"interventions":121},"RECRUITING",[73],"2025-06-25",750,[118,119,120],"Blood Pressure Management","Intraoperative Hypotension","Non-cardiac Surgery",[58,122],"standard blood pressure management",{"trials":124,"activeCount":82},[],{"trials":126,"activeCount":82},[],{"intervention":122,"totalTrials":78,"cells":128},{"EARLY_PHASE1":129,"PHASE1":131,"PHASE2":133,"PHASE3":135,"PHASE4":141,"NA":143},{"trials":130,"activeCount":82},[],{"trials":132,"activeCount":82},[],{"trials":134,"activeCount":82},[],{"trials":136,"activeCount":78,"soonestReadout":57},[137],{"nctId":55,"briefTitle":56,"status":113,"phases":138,"primaryCompletion":57,"completion":57,"start":115,"enrollment":116,"conditions":139,"interventions":140},[73],[118,119,120],[58,122],{"trials":142,"activeCount":82},[],{"trials":144,"activeCount":82},[],{"intervention":43,"totalTrials":78,"cells":146},{"EARLY_PHASE1":147,"PHASE1":149,"PHASE2":151,"PHASE3":153,"PHASE4":163,"NA":165},{"trials":148,"activeCount":82},[],{"trials":150,"activeCount":82},[],{"trials":152,"activeCount":82},[],{"trials":154,"activeCount":78,"soonestReadout":42},[155],{"nctId":40,"briefTitle":41,"status":113,"phases":156,"primaryCompletion":42,"completion":157,"start":158,"enrollment":159,"conditions":160,"interventions":161},[73],"2026-12","2021-08-01",600,[15],[43,162],"FLOT + Surgery",{"trials":164,"activeCount":82},[],{"trials":166,"activeCount":82},[],{"intervention":162,"totalTrials":78,"cells":168},{"EARLY_PHASE1":169,"PHASE1":171,"PHASE2":173,"PHASE3":175,"PHASE4":181,"NA":183},{"trials":170,"activeCount":82},[],{"trials":172,"activeCount":82},[],{"trials":174,"activeCount":82},[],{"trials":176,"activeCount":78,"soonestReadout":42},[177],{"nctId":40,"briefTitle":41,"status":113,"phases":178,"primaryCompletion":42,"completion":157,"start":158,"enrollment":159,"conditions":179,"interventions":180},[73],[15],[43,162],{"trials":182,"activeCount":82},[],{"trials":184,"activeCount":82},[],{"intervention":38,"totalTrials":78,"cells":186},{"EARLY_PHASE1":187,"PHASE1":189,"PHASE2":191,"PHASE3":193,"PHASE4":205,"NA":207},{"trials":188,"activeCount":82},[],{"trials":190,"activeCount":82},[],{"trials":192,"activeCount":82},[],{"trials":194,"activeCount":78,"soonestReadout":37},[195],{"nctId":35,"briefTitle":36,"status":196,"phases":197,"primaryCompletion":37,"completion":198,"start":199,"enrollment":200,"conditions":201,"interventions":204},"ACTIVE_NOT_RECRUITING",[73],"2026-06-30","2022-06-13",2146,[202,203],"Myocardial Injury After Noncardiac Surgery (MINS)","Myocardial Ischemia",[38],{"trials":206,"activeCount":82},[],{"trials":208,"activeCount":82},[],{"intervention":48,"totalTrials":78,"cells":210},{"EARLY_PHASE1":211,"PHASE1":213,"PHASE2":222,"PHASE3":224,"PHASE4":226,"NA":228},{"trials":212,"activeCount":82},[],{"trials":214,"activeCount":78,"soonestReadout":47},[215],{"nctId":45,"briefTitle":46,"status":113,"phases":216,"primaryCompletion":47,"completion":52,"start":217,"enrollment":218,"conditions":219,"interventions":221},[71],"2021-12-01",20,[220],"High-Risk Neuroblastoma",[48],{"trials":223,"activeCount":82},[],{"trials":225,"activeCount":82},[],{"trials":227,"activeCount":82},[],{"trials":229,"activeCount":82},[],{"intervention":63,"totalTrials":78,"cells":231},{"EARLY_PHASE1":232,"PHASE1":234,"PHASE2":236,"PHASE3":238,"PHASE4":240,"NA":242},{"trials":233,"activeCount":82},[],{"trials":235,"activeCount":82},[],{"trials":237,"activeCount":82},[],{"trials":239,"activeCount":82},[],{"trials":241,"activeCount":82},[],{"trials":243,"activeCount":78,"soonestReadout":62},[244],{"nctId":60,"briefTitle":61,"status":92,"phases":245,"primaryCompletion":62,"completion":62,"start":246,"enrollment":247,"conditions":248,"interventions":250},[75],"2026-02-01",200,[249],"Pain Management",[63],{"intervention":53,"totalTrials":78,"cells":252},{"EARLY_PHASE1":253,"PHASE1":255,"PHASE2":257,"PHASE3":259,"PHASE4":261,"NA":263},{"trials":254,"activeCount":82},[],{"trials":256,"activeCount":82},[],{"trials":258,"activeCount":82},[],{"trials":260,"activeCount":82},[],{"trials":262,"activeCount":82},[],{"trials":264,"activeCount":78,"soonestReadout":52},[265],{"nctId":50,"briefTitle":51,"status":113,"phases":266,"primaryCompletion":52,"completion":52,"start":267,"enrollment":268,"conditions":269,"interventions":272},[75],"2025-02-06",300,[270,271],"Regional Anaesthesia","Anesthesia and Analgesia",[53,273,274],"ESP block","Lidacaine",{"intervention":273,"totalTrials":78,"cells":276},{"EARLY_PHASE1":277,"PHASE1":279,"PHASE2":281,"PHASE3":283,"PHASE4":285,"NA":287},{"trials":278,"activeCount":82},[],{"trials":280,"activeCount":82},[],{"trials":282,"activeCount":82},[],{"trials":284,"activeCount":82},[],{"trials":286,"activeCount":82},[],{"trials":288,"activeCount":78,"soonestReadout":52},[289],{"nctId":50,"briefTitle":51,"status":113,"phases":290,"primaryCompletion":52,"completion":52,"start":267,"enrollment":268,"conditions":291,"interventions":292},[75],[270,271],[53,273,274],{"intervention":274,"totalTrials":78,"cells":294},{"EARLY_PHASE1":295,"PHASE1":297,"PHASE2":299,"PHASE3":301,"PHASE4":303,"NA":305},{"trials":296,"activeCount":82},[],{"trials":298,"activeCount":82},[],{"trials":300,"activeCount":82},[],{"trials":302,"activeCount":82},[],{"trials":304,"activeCount":82},[],{"trials":306,"activeCount":78,"soonestReadout":52},[307],{"nctId":50,"briefTitle":51,"status":113,"phases":308,"primaryCompletion":52,"completion":52,"start":267,"enrollment":268,"conditions":309,"interventions":310},[75],[270,271],[53,273,274],{"intervention":312,"totalTrials":313,"cells":314},"Peptisorb",2,{"EARLY_PHASE1":315,"PHASE1":317,"PHASE2":319,"PHASE3":321,"PHASE4":323,"NA":350},{"trials":316,"activeCount":82},[],{"trials":318,"activeCount":82},[],{"trials":320,"activeCount":82},[],{"trials":322,"activeCount":82},[],{"trials":324,"activeCount":82},[325,337],{"nctId":326,"briefTitle":327,"status":328,"phases":329,"completion":330,"start":331,"enrollment":332,"conditions":333,"interventions":335},"NCT00576940","Standard and Immunostimulating Enteral Nutrition in Surgical Patients","COMPLETED",[74],"2007-09","2004-06",196,[15,334],"Pancreatic Cancer",[336,312],"Reconvan",{"nctId":338,"briefTitle":339,"status":328,"phases":340,"completion":341,"start":342,"enrollment":343,"conditions":344,"interventions":345},"NCT00558155","The Impact of Immunostimulating Nutrition on the Outcome of Surgery",[74],"2005-12","2001-06",214,[15,334],[346,347,348,349],"peptisorb","Stresson","Parenteral nutrition","Omegaven, Dipeptiven",{"trials":351,"activeCount":82},[],{"intervention":348,"totalTrials":313,"cells":353},{"EARLY_PHASE1":354,"PHASE1":356,"PHASE2":358,"PHASE3":360,"PHASE4":362,"NA":380},{"trials":355,"activeCount":82},[],{"trials":357,"activeCount":82},[],{"trials":359,"activeCount":82},[],{"trials":361,"activeCount":82},[],{"trials":363,"activeCount":82},[364,368],{"nctId":338,"briefTitle":339,"status":328,"phases":365,"completion":341,"start":342,"enrollment":343,"conditions":366,"interventions":367},[74],[15,334],[346,347,348,349],{"nctId":369,"briefTitle":370,"status":328,"phases":371,"primaryCompletion":372,"completion":373,"start":374,"enrollment":375,"conditions":376,"interventions":378},"NCT01025414","Enteral Nutrition in the Treatment of Pancreatic Fistulas - A Prospective Study",[74],"2009-10","2009-11","2006-07",78,[377],"Pancreatic Fistula",[379,348],"enteral nutrition",{"trials":381,"activeCount":82},[],{"intervention":336,"totalTrials":78,"cells":383},{"EARLY_PHASE1":384,"PHASE1":386,"PHASE2":388,"PHASE3":390,"PHASE4":392,"NA":398},{"trials":385,"activeCount":82},[],{"trials":387,"activeCount":82},[],{"trials":389,"activeCount":82},[],{"trials":391,"activeCount":82},[],{"trials":393,"activeCount":82},[394],{"nctId":326,"briefTitle":327,"status":328,"phases":395,"completion":330,"start":331,"enrollment":332,"conditions":396,"interventions":397},[74],[15,334],[336,312],{"trials":399,"activeCount":82},[],{"intervention":401,"totalTrials":78,"cells":402},"Reconvan, Dipeptiven, Omegaven",{"EARLY_PHASE1":403,"PHASE1":405,"PHASE2":407,"PHASE3":409,"PHASE4":411,"NA":423},{"trials":404,"activeCount":82},[],{"trials":406,"activeCount":82},[],{"trials":408,"activeCount":82},[],{"trials":410,"activeCount":82},[],{"trials":412,"activeCount":82},[413],{"nctId":414,"briefTitle":415,"status":328,"phases":416,"primaryCompletion":417,"completion":418,"start":419,"enrollment":159,"conditions":420,"interventions":422},"NCT00732849","The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery",[74],"2002-09","2007-11","2002-06",[421],"Gastrointestinal Surgery",[401],{"trials":424,"activeCount":82},[],{"intervention":347,"totalTrials":78,"cells":426},{"EARLY_PHASE1":427,"PHASE1":429,"PHASE2":431,"PHASE3":433,"PHASE4":435,"NA":441},{"trials":428,"activeCount":82},[],{"trials":430,"activeCount":82},[],{"trials":432,"activeCount":82},[],{"trials":434,"activeCount":82},[],{"trials":436,"activeCount":82},[437],{"nctId":338,"briefTitle":339,"status":328,"phases":438,"completion":341,"start":342,"enrollment":343,"conditions":439,"interventions":440},[74],[15,334],[346,347,348,349],{"trials":442,"activeCount":82},[],{"intervention":349,"totalTrials":78,"cells":444},{"EARLY_PHASE1":445,"PHASE1":447,"PHASE2":449,"PHASE3":451,"PHASE4":453,"NA":459},{"trials":446,"activeCount":82},[],{"trials":448,"activeCount":82},[],{"trials":450,"activeCount":82},[],{"trials":452,"activeCount":82},[],{"trials":454,"activeCount":82},[455],{"nctId":338,"briefTitle":339,"status":328,"phases":456,"completion":341,"start":342,"enrollment":343,"conditions":457,"interventions":458},[74],[15,334],[346,347,348,349],{"trials":460,"activeCount":82},[],{"intervention":462,"totalTrials":78,"cells":463},"Gabapentin 300mg",{"EARLY_PHASE1":464,"PHASE1":466,"PHASE2":468,"PHASE3":470,"PHASE4":472,"NA":490},{"trials":465,"activeCount":82},[],{"trials":467,"activeCount":82},[],{"trials":469,"activeCount":82},[],{"trials":471,"activeCount":82},[],{"trials":473,"activeCount":82},[474],{"nctId":475,"briefTitle":476,"status":328,"phases":477,"primaryCompletion":478,"completion":479,"start":480,"enrollment":481,"conditions":482,"interventions":486},"NCT04653415","Large Doses of Methylprednisolone Combined With Gabapentin in Total Knee Arthroplasty",[74],"2020-01-01","2020-05-01","2019-06-01",160,[483,484,30,485],"Arthroplasty Complications","Knee Osteoarthritis","Perioperative Complication",[462,487,488,489],"Methylprednisolone 125 mg","Tablet","Normal Saline 10 mL",{"trials":491,"activeCount":82},[],{"intervention":487,"totalTrials":78,"cells":493},{"EARLY_PHASE1":494,"PHASE1":496,"PHASE2":498,"PHASE3":500,"PHASE4":502,"NA":508},{"trials":495,"activeCount":82},[],{"trials":497,"activeCount":82},[],{"trials":499,"activeCount":82},[],{"trials":501,"activeCount":82},[],{"trials":503,"activeCount":82},[504],{"nctId":475,"briefTitle":476,"status":328,"phases":505,"primaryCompletion":478,"completion":479,"start":480,"enrollment":481,"conditions":506,"interventions":507},[74],[483,484,30,485],[462,487,488,489],{"trials":509,"activeCount":82},[],{"intervention":488,"totalTrials":78,"cells":511},{"EARLY_PHASE1":512,"PHASE1":514,"PHASE2":516,"PHASE3":518,"PHASE4":520,"NA":526},{"trials":513,"activeCount":82},[],{"trials":515,"activeCount":82},[],{"trials":517,"activeCount":82},[],{"trials":519,"activeCount":82},[],{"trials":521,"activeCount":82},[522],{"nctId":475,"briefTitle":476,"status":328,"phases":523,"primaryCompletion":478,"completion":479,"start":480,"enrollment":481,"conditions":524,"interventions":525},[74],[483,484,30,485],[462,487,488,489],{"trials":527,"activeCount":82},[],{"intervention":489,"totalTrials":78,"cells":529},{"EARLY_PHASE1":530,"PHASE1":532,"PHASE2":534,"PHASE3":536,"PHASE4":538,"NA":544},{"trials":531,"activeCount":82},[],{"trials":533,"activeCount":82},[],{"trials":535,"activeCount":82},[],{"trials":537,"activeCount":82},[],{"trials":539,"activeCount":82},[540],{"nctId":475,"briefTitle":476,"status":328,"phases":541,"primaryCompletion":478,"completion":479,"start":480,"enrollment":481,"conditions":542,"interventions":543},[74],[483,484,30,485],[462,487,488,489],{"trials":545,"activeCount":82},[],{"intervention":547,"totalTrials":78,"cells":548},"Etanercept",{"EARLY_PHASE1":549,"PHASE1":551,"PHASE2":553,"PHASE3":555,"PHASE4":557,"NA":574},{"trials":550,"activeCount":82},[],{"trials":552,"activeCount":82},[],{"trials":554,"activeCount":82},[],{"trials":556,"activeCount":82},[],{"trials":558,"activeCount":82},[559],{"nctId":560,"briefTitle":561,"status":562,"phases":563,"primaryCompletion":564,"start":565,"enrollment":96,"conditions":566,"interventions":570},"NCT02132234","Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis","UNKNOWN",[74],"2014-07","2013-06",[567,568,569,25],"Rheumatoid Arthritis","Psoriatic Arthritis","Ankylosing Spondylitis",[547,571,572,573],"Adalimumab","Certolizumab","Infliximab",{"trials":575,"activeCount":82},[],{"intervention":571,"totalTrials":78,"cells":577},{"EARLY_PHASE1":578,"PHASE1":580,"PHASE2":582,"PHASE3":584,"PHASE4":586,"NA":592},{"trials":579,"activeCount":82},[],{"trials":581,"activeCount":82},[],{"trials":583,"activeCount":82},[],{"trials":585,"activeCount":82},[],{"trials":587,"activeCount":82},[588],{"nctId":560,"briefTitle":561,"status":562,"phases":589,"primaryCompletion":564,"start":565,"enrollment":96,"conditions":590,"interventions":591},[74],[567,568,569,25],[547,571,572,573],{"trials":593,"activeCount":82},[],{"intervention":572,"totalTrials":78,"cells":595},{"EARLY_PHASE1":596,"PHASE1":598,"PHASE2":600,"PHASE3":602,"PHASE4":604,"NA":610},{"trials":597,"activeCount":82},[],{"trials":599,"activeCount":82},[],{"trials":601,"activeCount":82},[],{"trials":603,"activeCount":82},[],{"trials":605,"activeCount":82},[606],{"nctId":560,"briefTitle":561,"status":562,"phases":607,"primaryCompletion":564,"start":565,"enrollment":96,"conditions":608,"interventions":609},[74],[567,568,569,25],[547,571,572,573],{"trials":611,"activeCount":82},[],{"intervention":573,"totalTrials":78,"cells":613},{"EARLY_PHASE1":614,"PHASE1":616,"PHASE2":618,"PHASE3":620,"PHASE4":622,"NA":628},{"trials":615,"activeCount":82},[],{"trials":617,"activeCount":82},[],{"trials":619,"activeCount":82},[],{"trials":621,"activeCount":82},[],{"trials":623,"activeCount":82},[624],{"nctId":560,"briefTitle":561,"status":562,"phases":625,"primaryCompletion":564,"start":565,"enrollment":96,"conditions":626,"interventions":627},[74],[567,568,569,25],[547,571,572,573],{"trials":629,"activeCount":82},[],{"intervention":379,"totalTrials":78,"cells":631},{"EARLY_PHASE1":632,"PHASE1":634,"PHASE2":636,"PHASE3":638,"PHASE4":640,"NA":646},{"trials":633,"activeCount":82},[],{"trials":635,"activeCount":82},[],{"trials":637,"activeCount":82},[],{"trials":639,"activeCount":82},[],{"trials":641,"activeCount":82},[642],{"nctId":369,"briefTitle":370,"status":328,"phases":643,"primaryCompletion":372,"completion":373,"start":374,"enrollment":375,"conditions":644,"interventions":645},[74],[377],[379,348],{"trials":647,"activeCount":82},[],{"intervention":649,"totalTrials":78,"cells":650},"Montelukast 10mg",{"EARLY_PHASE1":651,"PHASE1":653,"PHASE2":655,"PHASE3":657,"PHASE4":673,"NA":675},{"trials":652,"activeCount":82},[],{"trials":654,"activeCount":82},[],{"trials":656,"activeCount":82},[],{"trials":658,"activeCount":82},[659],{"nctId":660,"briefTitle":661,"status":562,"phases":662,"primaryCompletion":663,"completion":664,"start":665,"enrollment":247,"conditions":666,"interventions":671},"NCT04277702","Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease",[73],"2023-10","2023-12","2020-05",[667,668,669,670],"Peripheral Arterial Disease","Peripheral Vascular Diseases","Lower Limb Ischemia","Atherosclerosis of Artery",[649,672],"Standard anti-platelet treatment",{"trials":674,"activeCount":82},[],{"trials":676,"activeCount":82},[],{"intervention":672,"totalTrials":78,"cells":678},{"EARLY_PHASE1":679,"PHASE1":681,"PHASE2":683,"PHASE3":685,"PHASE4":691,"NA":693},{"trials":680,"activeCount":82},[],{"trials":682,"activeCount":82},[],{"trials":684,"activeCount":82},[],{"trials":686,"activeCount":82},[687],{"nctId":660,"briefTitle":661,"status":562,"phases":688,"primaryCompletion":663,"completion":664,"start":665,"enrollment":247,"conditions":689,"interventions":690},[73],[667,668,669,670],[649,672],{"trials":692,"activeCount":82},[],{"trials":694,"activeCount":82},[],{"intervention":696,"totalTrials":78,"cells":697},"MesoCellA-Ortho administration",{"EARLY_PHASE1":698,"PHASE1":700,"PHASE2":702,"PHASE3":715,"PHASE4":717,"NA":719},{"trials":699,"activeCount":82},[],{"trials":701,"activeCount":82},[],{"trials":703,"activeCount":82},[704],{"nctId":705,"briefTitle":706,"status":328,"phases":707,"primaryCompletion":708,"completion":708,"start":709,"enrollment":710,"conditions":711,"interventions":713},"NCT05081921","Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases",[71,72],"2024-02-20","2022-01-05",192,[712],"Osteoarthritis of Knee",[696,714],"HA administration",{"trials":716,"activeCount":82},[],{"trials":718,"activeCount":82},[],{"trials":720,"activeCount":82},[],{"intervention":714,"totalTrials":78,"cells":722},{"EARLY_PHASE1":723,"PHASE1":725,"PHASE2":727,"PHASE3":733,"PHASE4":735,"NA":737},{"trials":724,"activeCount":82},[],{"trials":726,"activeCount":82},[],{"trials":728,"activeCount":82},[729],{"nctId":705,"briefTitle":706,"status":328,"phases":730,"primaryCompletion":708,"completion":708,"start":709,"enrollment":710,"conditions":731,"interventions":732},[71,72],[712],[696,714],{"trials":734,"activeCount":82},[],{"trials":736,"activeCount":82},[],{"trials":738,"activeCount":82},[],{"intervention":740,"totalTrials":78,"cells":741},"[99mTc]Tc-TECANT1",{"EARLY_PHASE1":742,"PHASE1":754,"PHASE2":756,"PHASE3":758,"PHASE4":760,"NA":762},{"trials":743,"activeCount":82},[744],{"nctId":745,"briefTitle":746,"status":328,"phases":747,"primaryCompletion":748,"completion":748,"start":749,"enrollment":750,"conditions":751,"interventions":753},"NCT05871320","Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms",[70],"2023-06-30","2022-12-23",10,[752],"Neuroendocrine Tumors",[740],{"trials":755,"activeCount":82},[],{"trials":757,"activeCount":82},[],{"trials":759,"activeCount":82},[],{"trials":761,"activeCount":82},[],{"trials":763,"activeCount":82},[],{"intervention":765,"totalTrials":313,"cells":766},"Ropivacaine",{"EARLY_PHASE1":767,"PHASE1":769,"PHASE2":771,"PHASE3":773,"PHASE4":775,"NA":777},{"trials":768,"activeCount":82},[],{"trials":770,"activeCount":82},[],{"trials":772,"activeCount":82},[],{"trials":774,"activeCount":82},[],{"trials":776,"activeCount":82},[],{"trials":778,"activeCount":82},[779,791],{"nctId":780,"briefTitle":781,"status":328,"phases":782,"primaryCompletion":783,"completion":783,"start":784,"enrollment":785,"conditions":786,"interventions":789},"NCT05700214","Lidocaine Versus ESP - After Bariatric Surgery",[75],"2023-12-31","2023-02-01",279,[787,788],"Anesthetics","Local Anesthetics",[765,790],"Lidocaine IV",{"nctId":792,"briefTitle":793,"status":328,"phases":794,"primaryCompletion":795,"completion":783,"start":796,"enrollment":96,"conditions":797,"interventions":801},"NCT05446727","Quadratus Lumborum Block vs Erector Spinal Block for Post Abdomen Surgery Analgesia",[75],"2022-05-06","2022-05-01",[798,799,800],"Pain, Acute","Postoperative Pain","Anesthetics, Local",[765],{"intervention":803,"totalTrials":78,"cells":804},"levothyroxine",{"EARLY_PHASE1":805,"PHASE1":807,"PHASE2":809,"PHASE3":811,"PHASE4":813,"NA":815},{"trials":806,"activeCount":82},[],{"trials":808,"activeCount":82},[],{"trials":810,"activeCount":82},[],{"trials":812,"activeCount":82},[],{"trials":814,"activeCount":82},[],{"trials":816,"activeCount":82},[817],{"nctId":818,"briefTitle":819,"status":328,"phases":820,"primaryCompletion":821,"completion":822,"start":823,"enrollment":824,"conditions":825,"interventions":827},"NCT00941551","Thyroid Lobectomy With or Without Levothyroxine Treatment Postoperatively",[],"2003-12","2008-12","2000-01",150,[826],"Recurrent Goiter",[803,828],"no levothyroxine",{"intervention":828,"totalTrials":78,"cells":830},{"EARLY_PHASE1":831,"PHASE1":833,"PHASE2":835,"PHASE3":837,"PHASE4":839,"NA":841},{"trials":832,"activeCount":82},[],{"trials":834,"activeCount":82},[],{"trials":836,"activeCount":82},[],{"trials":838,"activeCount":82},[],{"trials":840,"activeCount":82},[],{"trials":842,"activeCount":82},[843],{"nctId":818,"briefTitle":819,"status":328,"phases":844,"primaryCompletion":821,"completion":822,"start":823,"enrollment":824,"conditions":845,"interventions":846},[],[826],[803,828],{"intervention":848,"totalTrials":78,"cells":849},"Nystatin",{"EARLY_PHASE1":850,"PHASE1":852,"PHASE2":854,"PHASE3":856,"PHASE4":858,"NA":860},{"trials":851,"activeCount":82},[],{"trials":853,"activeCount":82},[],{"trials":855,"activeCount":82},[],{"trials":857,"activeCount":82},[],{"trials":859,"activeCount":82},[],{"trials":861,"activeCount":82},[862],{"nctId":863,"briefTitle":864,"status":562,"phases":865,"primaryCompletion":866,"start":867,"enrollment":868,"conditions":869,"interventions":871},"NCT02166450","Effects of Denture-Related Stomatitis on Blood Pressure in Denture Wearers",[],"2015-12","2011-10",80,[870],"Denture Stomatitis",[848],{"intervention":790,"totalTrials":78,"cells":873},{"EARLY_PHASE1":874,"PHASE1":876,"PHASE2":878,"PHASE3":880,"PHASE4":882,"NA":884},{"trials":875,"activeCount":82},[],{"trials":877,"activeCount":82},[],{"trials":879,"activeCount":82},[],{"trials":881,"activeCount":82},[],{"trials":883,"activeCount":82},[],{"trials":885,"activeCount":82},[886],{"nctId":780,"briefTitle":781,"status":328,"phases":887,"primaryCompletion":783,"completion":783,"start":784,"enrollment":785,"conditions":888,"interventions":889},[75],[787,788],[765,790],{"intervention":891,"totalTrials":78,"cells":892},"Chlorhexidine",{"EARLY_PHASE1":893,"PHASE1":895,"PHASE2":897,"PHASE3":899,"PHASE4":901,"NA":903},{"trials":894,"activeCount":82},[],{"trials":896,"activeCount":82},[],{"trials":898,"activeCount":82},[],{"trials":900,"activeCount":82},[],{"trials":902,"activeCount":82},[],{"trials":904,"activeCount":82},[905],{"nctId":906,"briefTitle":907,"status":562,"phases":908,"primaryCompletion":909,"completion":909,"start":910,"enrollment":96,"conditions":911,"interventions":913},"NCT02131922","Study of the Effects of Intensive Treatment of Periodontitis on Blood Pressure Control",[75],"2014-09","2009-09",[912,25],"Periodontitis",[891],{"intervention":915,"totalTrials":78,"cells":916},"Ofloxacin + Metronidazole",{"EARLY_PHASE1":917,"PHASE1":919,"PHASE2":921,"PHASE3":923,"PHASE4":925,"NA":927},{"trials":918,"activeCount":82},[],{"trials":920,"activeCount":82},[],{"trials":922,"activeCount":82},[],{"trials":924,"activeCount":82},[],{"trials":926,"activeCount":82},[],{"trials":928,"activeCount":82},[929],{"nctId":930,"briefTitle":931,"status":328,"phases":932,"primaryCompletion":933,"completion":934,"start":935,"enrollment":936,"conditions":937,"interventions":940},"NCT05946655","Diagnostics of Chronic Endometritis in Infertility",[75],"2022-10-30","2024-10-30","2021-04-01",102,[23,938,939],"Abnormal Uterine Bleeding","Intrauterine Disorder",[915],{"intervention":942,"totalTrials":78,"cells":943},"MTX monotherapy",{"EARLY_PHASE1":944,"PHASE1":946,"PHASE2":948,"PHASE3":950,"PHASE4":952,"NA":954},{"trials":945,"activeCount":82},[],{"trials":947,"activeCount":82},[],{"trials":949,"activeCount":82},[],{"trials":951,"activeCount":82},[],{"trials":953,"activeCount":82},[],{"trials":955,"activeCount":82},[956],{"nctId":957,"briefTitle":958,"status":328,"phases":959,"primaryCompletion":960,"completion":961,"start":962,"enrollment":963,"conditions":964,"interventions":966},"NCT05839574","Letrozole add-on in the Treatment of Cesarean Scar Pregnancy",[75],"2022-12-30","2023-10-30","2021-01-01",28,[965],"Cesarean Scar Pregnancy",[942,967],"MTX + letrozole add-on",{"intervention":967,"totalTrials":78,"cells":969},{"EARLY_PHASE1":970,"PHASE1":972,"PHASE2":974,"PHASE3":976,"PHASE4":978,"NA":980},{"trials":971,"activeCount":82},[],{"trials":973,"activeCount":82},[],{"trials":975,"activeCount":82},[],{"trials":977,"activeCount":82},[],{"trials":979,"activeCount":82},[],{"trials":981,"activeCount":82},[982],{"nctId":957,"briefTitle":958,"status":328,"phases":983,"primaryCompletion":960,"completion":961,"start":962,"enrollment":963,"conditions":984,"interventions":985},[75],[965],[942,967],{"intervention":987,"totalTrials":78,"cells":988},"Bupivacaine",{"EARLY_PHASE1":989,"PHASE1":991,"PHASE2":993,"PHASE3":995,"PHASE4":997,"NA":999},{"trials":990,"activeCount":82},[],{"trials":992,"activeCount":82},[],{"trials":994,"activeCount":82},[],{"trials":996,"activeCount":82},[],{"trials":998,"activeCount":82},[],{"trials":1000,"activeCount":82},[1001],{"nctId":1002,"briefTitle":1003,"status":1004,"phases":1005,"primaryCompletion":1006,"completion":1006,"start":1007,"enrollment":1008,"conditions":1009,"interventions":1012},"NCT03606889","Quadratus Lumborum Block vs Transversus Abdominis Plane Block for Post-prostatectomy Analgesia","TERMINATED",[75],"2021-12-31","2018-07-31",12,[1010,30,1011,800],"Prostatic Cancer","Pain",[987],{"intervention":1014,"totalTrials":78,"cells":1015},"Verdye Green",{"EARLY_PHASE1":1016,"PHASE1":1018,"PHASE2":1020,"PHASE3":1022,"PHASE4":1024,"NA":1026},{"trials":1017,"activeCount":82},[],{"trials":1019,"activeCount":82},[],{"trials":1021,"activeCount":82},[],{"trials":1023,"activeCount":82},[],{"trials":1025,"activeCount":82},[],{"trials":1027,"activeCount":82},[1028],{"nctId":1029,"briefTitle":1030,"status":562,"phases":1031,"primaryCompletion":783,"completion":783,"start":1032,"enrollment":1033,"conditions":1034,"interventions":1035},"NCT05263336","Intraoperative Angiography Using ICG in Rectal Cancer Patients to Prevent Anastamotic Leak After Laparoscopic Anterior Resection of the Rectum",[75],"2021-01-03",180,[21],[1014],{"intervention":1037,"totalTrials":78,"cells":1038},"simvastatin",{"EARLY_PHASE1":1039,"PHASE1":1041,"PHASE2":1043,"PHASE3":1045,"PHASE4":1047,"NA":1049},{"trials":1040,"activeCount":82},[],{"trials":1042,"activeCount":82},[],{"trials":1044,"activeCount":82},[],{"trials":1046,"activeCount":82},[],{"trials":1048,"activeCount":82},[],{"trials":1050,"activeCount":82},[1051],{"nctId":1052,"briefTitle":1053,"status":562,"phases":1054,"primaryCompletion":1055,"completion":1056,"start":1057,"enrollment":96,"conditions":1058,"interventions":1060},"NCT00725829","Hypolipemic Treatment in Acute Coronary Syndrome (ACS): Antithrombotic Effects",[75],"2009-06","2009-12","2008-06",[1059],"Acute Coronary Syndrome",[1037,1061],"ezetimibe",{"intervention":1061,"totalTrials":78,"cells":1063},{"EARLY_PHASE1":1064,"PHASE1":1066,"PHASE2":1068,"PHASE3":1070,"PHASE4":1072,"NA":1074},{"trials":1065,"activeCount":82},[],{"trials":1067,"activeCount":82},[],{"trials":1069,"activeCount":82},[],{"trials":1071,"activeCount":82},[],{"trials":1073,"activeCount":82},[],{"trials":1075,"activeCount":82},[1076],{"nctId":1052,"briefTitle":1053,"status":562,"phases":1077,"primaryCompletion":1055,"completion":1056,"start":1057,"enrollment":96,"conditions":1078,"interventions":1079},[75],[1059],[1037,1061],{"intervention":1081,"totalTrials":78,"cells":1082},"Metformin",{"EARLY_PHASE1":1083,"PHASE1":1085,"PHASE2":1087,"PHASE3":1089,"PHASE4":1091,"NA":1093},{"trials":1084,"activeCount":82},[],{"trials":1086,"activeCount":82},[],{"trials":1088,"activeCount":82},[],{"trials":1090,"activeCount":82},[],{"trials":1092,"activeCount":82},[],{"trials":1094,"activeCount":82},[1095],{"nctId":1096,"briefTitle":1097,"status":328,"phases":1098,"primaryCompletion":960,"completion":1099,"start":158,"enrollment":1100,"conditions":1101,"interventions":1105},"NCT04947020","DataBase for Analysis of Rectal Cancer Oncological Results",[],"2024-12-31",2443,[21,1081,1102,1103,1104],"Overall Survival","Lymph Node Metastases","Disease-free Survival",[1081],{"intervention":1107,"totalTrials":78,"cells":1108},"estradiol",{"EARLY_PHASE1":1109,"PHASE1":1111,"PHASE2":1113,"PHASE3":1115,"PHASE4":1117,"NA":1119},{"trials":1110,"activeCount":82},[],{"trials":1112,"activeCount":82},[],{"trials":1114,"activeCount":82},[],{"trials":1116,"activeCount":82},[],{"trials":1118,"activeCount":82},[],{"trials":1120,"activeCount":82},[1121],{"nctId":1122,"briefTitle":1123,"status":328,"phases":1124,"primaryCompletion":960,"completion":1125,"start":1126,"enrollment":1127,"conditions":1128,"interventions":1132},"NCT05783479","Pharmacological Preparation of the Cervix for Hysteroscopy",[75],"2023-01-31","2022-06-01",96,[1129,1130,1131],"Uterine Polyp","Uterine Bleeding","Endometrium; Senility",[1107,1133],"Hyaluronic acid",{"intervention":1133,"totalTrials":78,"cells":1135},{"EARLY_PHASE1":1136,"PHASE1":1138,"PHASE2":1140,"PHASE3":1142,"PHASE4":1144,"NA":1146},{"trials":1137,"activeCount":82},[],{"trials":1139,"activeCount":82},[],{"trials":1141,"activeCount":82},[],{"trials":1143,"activeCount":82},[],{"trials":1145,"activeCount":82},[],{"trials":1147,"activeCount":82},[1148],{"nctId":1122,"briefTitle":1123,"status":328,"phases":1149,"primaryCompletion":960,"completion":1125,"start":1126,"enrollment":1127,"conditions":1150,"interventions":1151},[75],[1129,1130,1131],[1107,1133],{"intervention":1153,"totalTrials":78,"cells":1154},"Letrozole as monotherapy",{"EARLY_PHASE1":1155,"PHASE1":1157,"PHASE2":1159,"PHASE3":1161,"PHASE4":1163,"NA":1165},{"trials":1156,"activeCount":82},[],{"trials":1158,"activeCount":82},[],{"trials":1160,"activeCount":82},[],{"trials":1162,"activeCount":82},[],{"trials":1164,"activeCount":82},[],{"trials":1166,"activeCount":82},[1167],{"nctId":1168,"briefTitle":1169,"status":328,"phases":1170,"primaryCompletion":960,"completion":748,"start":1171,"enrollment":1172,"conditions":1173,"interventions":1175},"NCT05839561","Monotherapy With Letrozole in Tubal Pregnancy",[75],"2020-12-01",22,[1174],"Tubal Pregnancy Unruptured",[1153,1176],"MTX as monotherapy",{"intervention":1176,"totalTrials":78,"cells":1178},{"EARLY_PHASE1":1179,"PHASE1":1181,"PHASE2":1183,"PHASE3":1185,"PHASE4":1187,"NA":1189},{"trials":1180,"activeCount":82},[],{"trials":1182,"activeCount":82},[],{"trials":1184,"activeCount":82},[],{"trials":1186,"activeCount":82},[],{"trials":1188,"activeCount":82},[],{"trials":1190,"activeCount":82},[1191],{"nctId":1168,"briefTitle":1169,"status":328,"phases":1192,"primaryCompletion":960,"completion":748,"start":1171,"enrollment":1172,"conditions":1193,"interventions":1194},[75],[1174],[1153,1176],{"intervention":1196,"totalTrials":78,"cells":1197},"Selective alpha-1-antagonist",{"EARLY_PHASE1":1198,"PHASE1":1200,"PHASE2":1202,"PHASE3":1204,"PHASE4":1206,"NA":1208},{"trials":1199,"activeCount":82},[],{"trials":1201,"activeCount":82},[],{"trials":1203,"activeCount":82},[],{"trials":1205,"activeCount":82},[],{"trials":1207,"activeCount":82},[],{"trials":1209,"activeCount":82},[1210],{"nctId":1211,"briefTitle":1212,"status":328,"phases":1213,"primaryCompletion":1214,"completion":1215,"start":1216,"enrollment":1217,"conditions":1218,"interventions":1220},"NCT04557072","Selective Versus Nonselective Alpha-blockade Prior to Pheochromocytoma Resection - Systematic Review and Meta-analysis",[],"2020-09-01","2020-11-02","2020-08-01",1344,[1219],"Pheochromocytoma",[1196,1221],"Non-selective alpha-1-antagonist",{"intervention":1221,"totalTrials":78,"cells":1223},{"EARLY_PHASE1":1224,"PHASE1":1226,"PHASE2":1228,"PHASE3":1230,"PHASE4":1232,"NA":1234},{"trials":1225,"activeCount":82},[],{"trials":1227,"activeCount":82},[],{"trials":1229,"activeCount":82},[],{"trials":1231,"activeCount":82},[],{"trials":1233,"activeCount":82},[],{"trials":1235,"activeCount":82},[1236],{"nctId":1211,"briefTitle":1212,"status":328,"phases":1237,"primaryCompletion":1214,"completion":1215,"start":1216,"enrollment":1217,"conditions":1238,"interventions":1239},[],[1219],[1196,1221],{"intervention":1241,"totalTrials":78,"cells":1242},"Sonophoresis",{"EARLY_PHASE1":1243,"PHASE1":1245,"PHASE2":1247,"PHASE3":1249,"PHASE4":1251,"NA":1253},{"trials":1244,"activeCount":82},[],{"trials":1246,"activeCount":82},[],{"trials":1248,"activeCount":82},[],{"trials":1250,"activeCount":82},[],{"trials":1252,"activeCount":82},[],{"trials":1254,"activeCount":82},[1255],{"nctId":1256,"briefTitle":1257,"status":328,"phases":1258,"primaryCompletion":1259,"completion":1259,"start":1260,"enrollment":1261,"conditions":1262,"interventions":1264},"NCT03773640","The Application of Radio Frequency Waves",[75],"2018-12-05","2018-04-01",40,[1263],"Temporomandibular Joint Dysfunction Syndrome",[1241],{"intervention":1266,"totalTrials":78,"cells":1267},"TIVA versus Inhalation",{"EARLY_PHASE1":1268,"PHASE1":1270,"PHASE2":1272,"PHASE3":1274,"PHASE4":1276,"NA":1278},{"trials":1269,"activeCount":82},[],{"trials":1271,"activeCount":82},[],{"trials":1273,"activeCount":82},[],{"trials":1275,"activeCount":82},[],{"trials":1277,"activeCount":82},[],{"trials":1279,"activeCount":82},[1280],{"nctId":1281,"briefTitle":1282,"status":328,"phases":1283,"primaryCompletion":1099,"completion":1099,"start":1284,"enrollment":1285,"conditions":1286,"interventions":1289},"NCT06390046","Comparison of Total Intravenous Anesthesia and Inhalational Anesthesia in Opioid-Free Anesthesia for Bariatric Surgery: A Randomized Controlled Trial",[75],"2024-04-30",280,[1287,1288],"Analgesics, Opioid","Anesthesia; Adverse Effect",[1266]]